Plexus Corp. (NASDAQ:PLXS - Get Free Report) CEO Todd Kelsey sold 1,500 shares of Plexus stock in a transaction that occurred on Wednesday, October 21st. The shares were sold at an average price of $239.16, for a total value of $358,740.00. Following the transaction, the chief executive officer directly owned 62,888 shares in the company, valued at approximately $15,040,294.08. The trade was a 2.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Plexus Trading Down 7.5%
Shares of Plexus stock opened at $220.78 on Friday. The stock has a fifty day simple moving average of $250.63 and a 200 day simple moving average of $258.62. Plexus Corp. has a 12-month low of $132.03 and a 12-month high of $307.06. The company has a market capitalization of $5.91 billion, a P/E ratio of 35.21 and a beta of 0.88. The company has a current ratio of 1.49, a quick ratio of 0.72 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, beating analysts' consensus estimates of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. During the same period in the prior year, the firm posted $1.64 EPS. Plexus's quarterly revenue was up 28.2% compared to the same quarter last year. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. On average, sell-side analysts anticipate that Plexus Corp. will post 7.13 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on PLXS. Zacks Research upgraded shares of Plexus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. Needham & Company LLC restated a "buy" rating and set a $310.00 price target on shares of Plexus in a report on Friday, August 14th. Wall Street Zen raised shares of Plexus from a "hold" rating to a "buy" rating in a research report on Sunday, October 4th. Sidoti upgraded shares of Plexus from a "neutral" rating to a "buy" rating and set a $308.00 price objective for the company in a research note on Friday, July 31st. Finally, Weiss Ratings raised shares of Plexus from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, October 8th. One research analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $276.86.
Get Our Latest Stock Report on Plexus
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the business. Louisiana State Employees Retirement System bought a new stake in shares of Plexus during the 1st quarter worth $2,410,000. Walleye Capital LLC bought a new position in Plexus during the second quarter valued at about $8,296,000. Congress Asset Management Co. grew its position in Plexus by 204.0% during the third quarter. Congress Asset Management Co. now owns 315,396 shares of the technology company's stock valued at $82,303,000 after buying an additional 211,663 shares during the period. Inspire Investing LLC increased its holdings in Plexus by 239.5% during the first quarter. Inspire Investing LLC now owns 10,789 shares of the technology company's stock worth $2,185,000 after buying an additional 7,611 shares during the last quarter. Finally, Bank of America Corp DE purchased a new stake in Plexus during the second quarter worth about $60,281,000. Institutional investors own 94.45% of the company's stock.
About Plexus
(
Get Free Report)
Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.
Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
